What You Should Know:
- Horizon Health Network, operating across New Brunswick, Canada, has partnered with global health tech leader Qure.ai to implement a comprehensive AI suite for lung cancer care.
- The strategic collaboration is designed to prepare the health system for a province-wide screening program while simultaneously deploying AI to detect "incidental" lung nodules in routine X-rays and CT scans. By integrating tools for detection, quantification, and patient
Read More
Lung Cancer
Microsoft Partners with Qure.ai to Accelerate AI Lung Cancer Detection
What You Should Know:
- Qure.ai, a TIME100 most influential company and global leader in digital healthcare, today announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer detection, measurement and management suite of AI-powered solutions onto the Precision Imaging Network.
- This will streamline deployment of Qure.ai solutions to hospitals and health systems across the USA, driving digital healthcare transformation, improved tech integrations and
Read More
Oatmeal Health and Coreline Soft Partner to Distribute AI-Powered Lung Cancer Screening in U.S.
What You Should Know:
- Oatmeal Health and Coreline Soft, a publicly traded leader in AI imaging from South Korea and the U.S., have partnered to co-develop and distribute AI-powered lung cancer screening solutions across the U.S.
- The strategic collaboration aims to accelerate equitable access to early detection and screening for the communities that need it most.
Expanding Lung Cancer Screening Access in FQHCs
According to the Lung Cancer Foundation of America, lung
Read More
Oatmeal Health Unveils AI Diagnostic Platform for Lung Cancer Screening in Underserved FQHC Communities
What You Should Know:
- Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
- The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare, making it more accessible and affordable for healthcare providers and patients.
AI-Powered Lung Nodule Analysis
Lung cancer remains a leading cause of cancer-related deaths worldwide, but screening rates remain
Read More
PrognomiQ Raises $34M to Advance Multi-Omics Early Detection Test for Lung Cancer
What You Should Know:
- PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing investors including Catalio Capital Management, aMoon, Invus and Bruker.
- The funding brings PrognomiQ’s total funding to more than $135M and will accelerate the development of PrognomiQ's early detection test for lung cancer.
Enhancing Lung
Read More
Nebraska Medicine & CancerIQ Boost Lung Cancer Risk Assessments by 6x
What You Should Know:
- Nebraska Medicine, the clinical partner of the University of Nebraska Medical Center, achieved a nearly 6x increase in lung cancer risk assessment completion through a collaboration with CancerIQ, a best-in-class cancer-focused precision health platform.
- The results of the lung cancer early detection campaign, which focused on risk assessment outside of the clinical setting, will be presented at the upcoming Association of Cancer Care Centers (ACCC) National
Read More
AI Breakthrough for Lung Disease: Thirona’s LungQ Receives FDA Clearance
What You Should Know:
- Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0.
- This FDA clearance paves the way for American hospitals to now harness the software's advanced capabilities, marking a significant step forward in lung disease diagnosis and treatment.
LungQ 3.0.0: Precision Navigation for Lung Interventions
This latest
Read More
Sheba Medical Deploys AI Lung Cancer Diagnostics Platform
What You Should Know:
- Sheba Medical Center, Israel’s largest medical center, today announced the deployment of a new accelerated, AI-powered cancer diagnostics research platform that can shorten diagnostic time from three weeks to minutes.
- The platform integrates technology developed by Sheba, in addition to innovative digital health startups, to accelerate the pathology department’s diagnostic capabilities.
- The first algorithm incorporated, developed by precision oncology
Read More
Notable Leverages GPT to Automate Patient Front Office Experience
What You Should Know:
Notable, an intelligent automation company for healthcare, launches Patient AI, a solution leveraging large language models (LLMs) and GPT (the technology powering ChatGPT) to bring personalization at scale to healthcare.Using GPT to scan existing clinical documentation, this tech can detect missed diagnoses, identify lapsed insurance cards, incorrect addresses, eligible clinical trials, or costly care gaps in real-time across an entire patient population.
How
Read More
Protai Raises $20M to Build an Oncology Drug Discovery Pipeline
What You Should Know:
- Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to $20M.
- The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data
Read More
